We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $71.2B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
AUM
$36.8B
AUM Growth
+$3.19B
Cap. Flow
+$703M
Cap. Flow %
1.91%
Top 10 Hldgs %
22.12%
Holding
943
New
16
Increased
564
Reduced
312
Closed
28

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$162M
2
WTW icon
Willis Towers Watson
WTW
+$116M
3
COP icon
ConocoPhillips
COP
+$114M
4
KO icon
Coca-Cola
KO
+$114M
5
AAPL icon
Apple
AAPL
+$108M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$111M
2
ICLR icon
Icon
ICLR
+$81.9M
3
FDX icon
FedEx
FDX
+$72.6M
4
GNRC icon
Generac Holdings
GNRC
+$55.6M
5
BBD icon
Banco Bradesco
BBD
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.05%
2 Healthcare 15.36%
3 Financials 14.29%
4 Consumer Discretionary 9.48%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.71T
$2.03B 5.53%
8,485,356
+246,295
+3% +$59.1M
AAPL icon
2
Apple
AAPL
$4.67T
$1.49B 4.05%
11,461,597
+757,380
+7% +$108M
AMZN icon
3
Amazon
AMZN
$2.79T
$791M 2.15%
9,415,023
-36,838
-0.4% -$3.64M
MA icon
4
Mastercard
MA
$507B
$617M 1.68%
1,774,545
+41,382
+2% +$13.6M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.14T
$606M 1.65%
6,873,871
-442,573
-6% -$42.1M
MRK icon
6
Merck
MRK
$371B
$573M 1.56%
5,165,852
+481,739
+10% +$49.2M
UNH icon
7
UnitedHealth
UNH
$356B
$573M 1.56%
1,080,995
+143,403
+15% +$76M
KO icon
8
Coca-Cola
KO
$379B
$556M 1.51%
8,738,479
+1,880,372
+27% +$114M
ABBV icon
9
AbbVie
ABBV
$453B
$459M 1.25%
2,837,182
-30,313
-1% -$4.65M
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.1T
$434M 1.18%
4,890,361
+45,642
+0.9% +$4.36M
TJX icon
11
TJX Companies
TJX
$145B
$407M 1.11%
5,117,446
-149,363
-3% -$11M
HD icon
12
Home Depot
HD
$320B
$403M 1.1%
1,275,424
+105,971
+9% +$32.3M
PG icon
13
Procter & Gamble
PG
$340B
$381M 1.04%
2,516,426
+27,795
+1% +$3.9M
ACN icon
14
Accenture
ACN
$114B
$366M 0.99%
1,369,923
+51,607
+4% +$14.3M
SCHW
15
Charles Schwab
SCHW
$189B
$356M 0.97%
4,275,565
+356,407
+9% +$27.7M
BSX icon
16
Boston Scientific
BSX
$69.3B
$352M 0.96%
7,608,933
-362,182
-5% -$15.7M
AVGO icon
17
Broadcom
AVGO
$1.7T
$351M 0.95%
6,274,770
+147,110
+2% +$7.38M
EMR icon
18
Emerson Electric
EMR
$85.2B
$311M 0.85%
3,241,205
-108,098
-3% -$9.72M
LLY icon
19
Eli Lilly
LLY
$1.02T
$296M 0.8%
809,078
-65,845
-8% -$23.3M
GS icon
20
Goldman Sachs
GS
$302B
$284M 0.77%
827,398
+2,530
+0.3% +$881K
NEE icon
21
NextEra Energy
NEE
$174B
$281M 0.77%
3,365,666
-42,474
-1% -$3.43M
AMT icon
22
American Tower
AMT
$81.9B
$280M 0.76%
1,322,161
+33,469
+3% +$6.97M
CVS icon
23
CVS Health
CVS
$124B
$280M 0.76%
3,004,819
+29,071
+1% +$2.81M
BAC icon
24
Bank of America
BAC
$438B
$277M 0.75%
8,357,285
+399,861
+5% +$13.8M
BKR icon
25
Baker Hughes
BKR
$63B
$267M 0.73%
9,031,886
+285,190
+3% +$7.87M

Similar funds

Aberdeen Group's Q4 2022 Portfolio in Review

As of Q4 2022, Aberdeen Group held 943 positions worth $36.8B, up 9.5% from $33.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.7%. Aberdeen Group opened 16 new positions and exited 28, leaving the 943-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Aberdeen Group's largest Q4 2022 buy was Ferguson: 365,292 shares worth $46.4M.
  • Aberdeen Group added most to Danaher in Q4 2022, an estimated $162M increase.
  • Aberdeen Group's biggest Q4 2022 reduction was Philip Morris, cutting an estimated $111M.
  • Aberdeen Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $40.3M.
  • Aberdeen Group's ten largest holdings make up 22% of its $36.8B portfolio in Q4 2022.
  • Aberdeen Group opened 16 new positions and closed 28 in Q4 2022.
  • Aberdeen Group's portfolio value rose 9.5% quarter-over-quarter to $36.8B.

Based on Aberdeen Group's 13F filing for Q4 2022, filed 10 Feb 2023.